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Abstract Proton leak pathways uncouple substrate oxida-
tion from ATP synthesis in mitochondria. These pathways
are classified as basal (not regulated) or inducible (activated
and inhibited). Previously it was found that over half of the
basal proton conductance of muscle mitochondria was
catalyzed by the adenine nucleotide translocase (ANT), an
abundant mitochondrial anion carrier protein. To determine
whether ANT is the unique protein catalyst, or one of many
proteins that catalyze basal proton conductance, we
measured proton leak kinetics in mitochondria isolated
from brown adipose tissue (BAT). BAT can express another
mitochondrial anion carrier, UCP1, at concentrations
similar to ANT. Basal proton conductance was measured
under conditions where UCP1 and ANT were catalytically
inactive and was found to be lower in mitochondria from
UCP1 knockout mice compared to wild-type. Ablation of
another abundant inner membrane protein, nicotinamide
nucleotide transhydrogenase, had no effect on proton leak
kinetics in mitochondria from liver, kidney or muscle,
showing that basal proton conductance is not catalyzed by
all membrane proteins. We identify UCP1 as a second
protein propagating basal proton leak, lending support to
the hypothesis that basal leak pathways are perpetrated by
members of the mitochondrial anion carrier family but not
by other mitochondrial inner membrane proteins.
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During oxidative phosphorylation, substrates are oxidized by
the mitochondrial electron transport chain, resulting in the
pumping of protons out of the mitochondrial matrix. This
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proton pumping establishes a protonmotive force across the
inner membrane, which is used by the F1FO-ATP synthase to
synthesize ATP. There is, however, a futile cycle of proton
pumping and proton leak (Brand et al. 1994; Nicholls et al.
1984) that may account for up to 25% of energy metabolism
in a resting organism (Rolfe and Brand 1996, 1997). Proton
leak pathways can be divided into two categories: inducible
and basal. By definition, inducible leak can be activated or
inhibited. Inducible pathways have been extensively inves-
tigated (Beck et al. 2007; Brand and Esteves 2005; Esteves
and Brand 2005; Gonzalez-Barroso et al. 1998). Inducible
leak is catalyzed by mitochondrial inner membrane carrier
proteins, notably the uncoupling proteins (UCP1, UCP2 and
UCP3) (Echtay et al. 2002; Esteves and Brand 2005) and the
adenine nucleotide translocase (ANT) (Andreyev et al. 1989;
Echtay et al. 2003; Parker et al. 2008a). Activators of
inducible proton leak pathways include small molecules such
as fatty acids (Andreyev et al. 1989; Esteves et al. 2006) or
reactive oxygen species and their peroxidation products
(Echtay et al. 2002, 2003; Parker et al. 2008b). Inducible
proton leak is inhibited by the putative endogenous
substrates of the mitochondrial carriers (Samartsev et al.
1997), purine nucleotides (Christiansen. 1971; Parker et al.
2008a), carboxyatractylate or bongkrekate (Azzu et al. 2008;
Parker et al. 2008a).
Basal proton conductance is defined as the leak of protons
into the mitochondrial matrix that occurs even when
regulatable uncoupling pathways are inhibited. Genetic
manipulation of ANT concentration in muscle mitochondria
isolated from mice and fruit flies greatly altered basal proton
conductance even when the carrier was fully inhibited with
carboxyatractylate (Brand et al. 2005), showing that the ANT
is the major contributor to basal proton conductance in these
mitochondria. There are two interpretations of this result.
Either ANT is the unique inner membrane protein respon-
sible for basal proton conductance or other proteins are
involved in this reaction and the major contribution of ANT
is simply a result of its abundance (1–10% of total protein
mass in mitochondria from all tissues tested). Of other
uncoupling proteins, it is unsurprising that ablation of UCP2
and UCP3 in mice does not lead to a decrease in basal
metabolism (Gong et al. 2000; Vidal-Puig et al. 2000; Zhang
et al. 2001) or lowered basal proton conductance in
mitochondria (Arsenijevic et al. 2000; Cadenas et al.
2002), since they only contribute 0.03% and 0.01% of total
mitochondrial protein respectively (Azzu et al. 2008; Harper
et al. 2002) and are not ubiquitous. By comparison, in wild-
type mice maintained at room temperature (21–23 °C),
UCP1 is present in brown adipose tissue (BAT) mitochon-
dria at concentrations similar to ANT (Stuart et al. 2001),
providing a rare opportunity to test the basal proton
conductance activity of a second member of the mitochon-
drial anion transport protein family.
In this paper we examine UCP1 as a candidate
mitochondrial inner membrane carrier protein involved in
basal proton conductance under conditions of limiting
endogenous fatty acids and full catalytic inhibition of both
UCP1 and ANT. We find that BAT mitochondria from
UCP1 knockout mice have significantly lower basal proton
conductance than wild-type controls; UCP1 catalyzes about
75% of basal proton conductance in these mitochondria.
We also show that another abundant, non-anion carrier
inner membrane protein, nicotinamide nucleotide trans-
hydrogenase (NNT), does not catalyze basal proton
conductance in mitochondria from liver, kidney and
muscle, implying that basal proton leak may be a unique




Male and female mice were housed at 21±2 °C, 57±5%
humidity, 12/12 h light/dark, with standard chow and water
ad libitum, following UK Home Office Guidelines for the
Care and Use of Laboratory Animals. Ucp1+/− mice were
used to derive Ucp1−/− (termed Ucp1KO) (Enerback et al.
1997) and wild-type, sibling paired mice. Nnt+/− (derived
from a naturally occurring mutation in the C57Bl/6 line
(Toye et al. 2005) crossed onto a wild-type 129 Sv strain)
mice were used to derive Nnt−/− (termed NntKO) and wild-
type sibling paired mice. Experimental animals were used
at age 7–12 months. Ucp1 and Nnt ablation was confirmed
by PCR analysis of the respective genomic loci.
Isolation of mitochondria
Animals were killed by stunning followed by cervical
dislocation and tissue was collected. All subsequent steps
were carried out at 4 °C.
Liver, kidney and BAT mitochondria were isolated
essentially as described (Echtay et al. 2002; Esteves et al.
2006). Tissue was placed in STE buffer (250 mM sucrose,
5 mM Tris/HCl, 2 mM EGTA, pH 7.4; supplemented with
1% (w/v) defatted BSA for BAT), minced and homogenized
with a Dounce homogenizer. Homogenates were filtered
through two layers of gauze and centrifuged at 8,500 g
(10 min). The resulting pellets were resuspended in STE
(+ BSA for BAT) and centrifuged at 700 g (10 min). The
supernatant was recovered and centrifuged at 8,500 g
(10 min). The pellet was suspended in STE, re-centrifuged
and finally resuspended in STE.
Skeletal muscle mitochondria were isolated as described
(Cadenas et al. 2002). Tissue was collected in CP1 buffer
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(100 mM KCl, 50 mM Tris/HCl, 2 mM EGTA, pH 7.4) and
minced with a sharp blade, then incubated for 3 min in CP1
supplemented with 1 mM ATP, 5 mM MgCl2, 0.5% (w/v)
defatted BSA, and 2.5 U/ml protease (type VIII). Homoge-
nates were centrifuged at 490 g (10 min), and the supernatant
was filtered through two layers of gauze then centrifuged at
10,400 g (10 min). The pellet was resuspended in CP1,
centrifuged at 10,400 g (10 min), resuspended and centri-
fuged at 3,840 g (10 min). The final pellet was resuspended
in CP1. Protein concentration was determined by the Biuret
method.
Proton-leak kinetics
Proton leak rate across the mitochondrial inner membrane (in
the presence of oligomycin to prevent ATP synthesis) was
measured as the oxygen consumption required to translocate
the leaked protons back out of the mitochondrial matrix. The
kinetics of proton leak were measured as a function of
the driving force, mitochondrial membrane potential (in the
presence of nigericin to convert the pH component of
protonmotive force to membrane potential) (Rolfe et al.
1994) and as such are independent of the substrate used to
energize the mitochondria. Membrane potentials and respi-
ration rates were measured simultaneously using electrodes
sensitive to the membrane-potential dependent probe,
TPMP+ (triphenylmethylphosphonium), or oxygen. Mito-
chondria (0.35 mg of protein/ml) were incubated in assay
medium containing (for hypotonic medium (Nicholls et al.
1972)) 50 mM KCl, 4 mM KH2PO4, 5 mM Hepes, 1 mM
EGTA, 4% (w/v) defatted BSA (BAT) or, (for isotonic
medium) 120 mM KCl, 5 mM KH2PO4, 3 mM Hepes,
1 mM EGTA 0.3% (w/v) defatted BSA (liver, kidney and
skeletal muscle). Pilot studies showed that, although there
was a decrease in proton leak between BAT mitochondria
incubated with 3% BSA compared to 1% BSA, no further
decrease was observed at 4% BSA, suggesting 4% BSA is
sufficient to sequester endogenous free fatty acids. All assay
media were supplemented with 5 μM rotenone, 1 μg/ml
oligomycin, 0.11 μM nigericin and 2.5 μM carboxyatracty-
late and brought to pH 7.2. The TPMP+ electrode was
calibrated with sequential additions of TPMP+ up to 2.5 μM
and the mitochondria were energized with 10 mM glycerol-
3-phosphate (BAT) or 4 mM succinate (other tissues).
Membrane potential was decreased by sequential additions
of the complex IV inhibitor KCN (14–230 μM) (BAT) or the
competitive inhibitor malonate (0.1–2.3 mM) (other tissues).
0.2 μM FCCP (carbonyl cyanide p-trifluoromethoxyphenyl-
hydrazone) was added at the end of the run to release matrix
TPMP+ to allow for correction of any baseline drift. A
correction of 0.4 (μl/mg protein)−1 (liver) or 0.35 (μl/mg
protein)−1 (BAT and other tissues) was used to correct for
TPMP binding; these values automatically correct for any
changes in matrix volume (Brand 1995). Of note, the use of
TPMP binding correction values quoted by Monemdjou et al.
(1999) (0.20 and 0.25 (μl/mg protein)−1 for wild-type and
Ucp1KO respectively) affected neither the direction nor the
statistical significance of differences in basal proton conduc-
tance between wild-type and Ucp1KO BAT mitochondria.
Western blot
Following isolation, mitochondria were solubilized in gel
loading buffer (2% (w/v) SDS, 10% (v/v) glycerol, 1% (v/v)
β-mercaptoethanol, 0.01% (w/v) bromophenol blue, 1 mM
EDTA, 50 mM Tris-HCl, pH 6.8) and stored at −80 °C until
use. Mitochondrial protein from thawed samples was
separated on SDS/12% polyacrylamide gels, transferred to
PVDF membranes (1 h at 100 V) and incubated overnight
(4 °C) in blocking buffer (0.1% (v/v) Tween 20 and 5% (w/v)
skimmed milk powder (Marvel) in phosphate-buffered
saline). Membranes were probed with a rabbit anti-UCP1
polyclonal antibody (1:20 000 dilution; U6382, Sigma) or a
goat anti-ANT polyclonal antibody (1:250 dilution; sc-9300,
Santa Cruz Biotechnology, Santa Cruz, CA, USA), followed
by the relevant peroxidase-conjugated secondary antibody
(anti-rabbit at 1:20 000 dilution or anti-goat at 1:5,000
dilution; Pierce Biotechnology, Rockford, IL, USA). All
antibody incubations were for 1 h at room temperature in
blocking buffer. Antigens were visualized on Amersham
Hyperfilm using an ECL Plus Western Blotting Detection
system (Amersham Biosciences, Little Chalfont, Bucks.,
UK). For the quantification of ANT, band intensities were
analyzed using ImageJ software (http://rsb.info.nih.gov/ij/).
For all blots, signal intensities were found to be linearly
dependent upon the amount of mitochondrial protein loaded
(5 to 20 µg per lane), confirming consistent loading and that
the signal was not saturating.
Statistics
Respiration rates (by linear interpolation between flanking
points) were calculated at the highest membrane potential
common to all conditions on a given day. ANOVA was
used to test for differences in these respiration rates.
Results
Pathways of proton conductance in brown adipose tissue
The mitochondrial carrier protein, UCP1, is known for its
ability to catalyze inducible proton leak across the inner
membrane of brown adipose tissue mitochondria in the
presence of free fatty acids (FFA). We have investigated the
ability of UCP1 to catalyze inducible and basal proton leak
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with limiting endogenous FFA (4% (w/v) defatted BSA
present) with ANT fully inhibited by carboxyatractylate
(Fig. 1).
Figure 1a shows that, as expected, addition of a low
concentration (160 μM) of palmitate (closed symbols)
increased the proton conductance of wild-type BAT
mitochondria containing UCP1 (squares), shifting the
proton leak curve upwards such that measurement of proton
leak kinetics remained possible. Addition of higher con-
centrations of palmitate led to near complete uncoupling of
the BAT mitochondria. At 147 mV, the highest potential
common to all experiments, 160 μM palmitate caused a
significant increase in oxygen consumption rate driving
proton leak (Fig. 1b), demonstrating that palmitate activates
proton conductance in these mitochondria. Addition of
160 µM palmitate significantly induced proton conductance
in BAT mitochondria containing UCP1, but had no effect
on the proton conductance of BAT mitochondria in which
UCP1 was ablated (Fig. 1a, triangles; Fig. 1b), demonstrat-
ing that palmitate was acting through UCP1 under these
conditions.
Even in the absence of exogenous fatty acids, BAT
mitochondria isolated from wild-type mice (Fig. 1a, open
squares) still had significantly greater proton conductance
than BAT mitochondria isolated from Ucp1KO mice
(Fig. 1a, open triangles; Fig. 1b). This might represent
residual UCP1 activity independent of fatty acids (Rial et
al. 2004; Shabalina et al. 2004) or activity caused by
contaminating fatty acids even in the presence of high BSA
(Garlid et al. 1996). Alternatively, it may represent basal
proton conductance caused by catalytically inactive UCP1.
To distinguish residual inducible activity from basal proton
conductance, we repeated the experiments in the presence
of 1 mM GDP, previously demonstrated to fully inhibit
fatty acid-activated UCP1 (Shabalina et al. 2004). GDP did
not significantly recouple the BAT mitochondria from wild-
type mice suggesting that high BSA was successful in
preventing activation of the endogenous UCP1. Figure 1c
demonstrates that, even after inhibition of UCP1, wild-type
BAT mitochondria (light grey squares) had greater proton
conductance than Ucp1KO mitochondria (light grey tri-
angles) at membrane potentials above about 125 mV.
Fig. 1 Contribution of UCP1 to inducible and basal proton conduc-
tance in brown adipose tissue mitochondria. a and c show the kinetics of
proton leak in BAT mitochondria isolated from wild-type (squares) and
Ucp1KO mice (triangles) measured as described in Materials and
Methods in the presence of 4% (w/v) defatted BSA and 2.5 μM CAT.
The kinetic response of mitochondrial proton leak rate (measured as
oxygen consumption rate) after energization with 10 mM glycerol-3-
phosphate was measured (a) in the absence (open symbols) or presence
(closed symbols) of 160 μM palmitate or (c) in the presence of 1 mM
GDP (light grey symbols) or 3 mM GDP (dark grey symbols). b and d
show the proton leak rate at 147 mV (solid vertical lines in A and C),
the average highest membrane potential common to all curves; shading
of bars corresponds to the shading of points in (a) and (c). Values are
means ± S.E.M. of four experiments. One-way ANOVAwas performed
for b; P=0.0001, and d; P=0.0014, with Tukey’s multiple comparison
test used post-hoc; * P<0.05, ** P<0.01
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Figure 1d shows respiration rates measured at 147 mV, the
highest potential common to all experiments. The proton
conductance of wild-type mitochondria containing catalyt-
ically inhibited UCP1 was significantly greater than the
proton conductance of Ucp1KO mitochondria under the
same conditions (light grey bars). To ensure that maximal
inhibition of UCP1 had been achieved, proton leak kinetics
were also measured in the presence of 3 mM GDP.
Figure 1c and d show that there was no further inhibition
of proton conductance at 3 mM GDP. These results show
that UCP1 makes a major contribution (about 75%) to basal
proton conductance in BAT mitochondria even when it is
fully inhibited by GDP in the presence of high BSA and
absence of exogenous fatty acids.
Regulation of ANT in Ucp1KO BAT mitochondria
The adenine nucleotide translocase contributes to both
inducible (Andreyev et al. 1989; Samartsev et al. 1997)
and basal (Brand et al. 2005) proton conductance. The
proton leak kinetics shown in Fig. 1 were measured in the
presence of the tight-binding inhibitor carboxyatractylate to
prevent ANT-catalyzed inducible leak. However, any
changes in ANT content caused by ablation of UCP1
would change the total contribution of ANT to basal proton
conductance (which is insensitive to carboxyatractylate)
and lead to an incorrect assessment of UCP1-mediated
basal proton conductance. To assess the contribution of
ANT content to differences in basal proton conductance, the
amount of ANT was quantified.
Figure 2a shows that UCP1 was detected in mitochon-
dria isolated from wild-type BAT but not in those from
Ucp1KO BAT, but ANT was detected in both types of
mitochondria. The ANT content in three separate paired
wild-type and UCP1 knockout BAT mitochondrial prepa-
rations was measured by quantitative immunoassay. There
was no difference (Fig. 2b), so secondary changes in ANT
content do not explain the effects of UCP1 knockout on
basal proton conductance.
Contribution of transhydrogenase to basal proton
conductance
The nicotinamide nucleotide transhydrogenase (NNT) con-
stitutes 0.5–2% of total mitochondrial protein (Hojeberg and
Rydstrom 1977; Wu et al. 1982), and was examined as an
abundant representative of a different inner membrane
protein family. Proton leak kinetics were measured in
mitochondria isolated from wild-type and NntKO mice.
The proton leak kinetics in mitochondria isolated from liver
(Fig. 3a), kidney (Fig. 3b) or skeletal muscle (Fig. 3c) were
similar when comparing wild-type (open symbols) with
NntKO (closed symbols). Although there were the expected
qualitative differences in proton conductance between
different tissues (Rolfe et al. 1994), there were no significant
differences in proton conductance with or without NNT
(Fig. 3d). These data show that NNT does not catalyze basal
proton conductance under the conditions tested.
Discussion
In this paper we examine the contribution of two different
mitochondrial inner membrane proteins to basal proton
conductance. It was previously shown that genetic modifi-
cation of levels of ANT significantly alters basal proton
conductance in isolated mitochondria (Brand et al. 2005).
We show here that there was significantly reduced basal
proton conductance in BAT mitochondria lacking UCP1
protein, in the presence of saturating levels of inhibitors of
Fig. 2 ANT content in mitochondria from wild-type and Ucp1KO
mice. a. Representative western blots of UCP1 and ANT in BAT
mitochondria (10 μg/lane) isolated from wild-type and Ucp1KO mice.
The UCP1 and ANT signals correspond to apparent molecular weights
of ∼32 and ∼30 kDa, respectively. b. Densitometric quantification of
ANT. ANT signal intensities were normalized to the total protein
loaded into the wells, as determined by accurate protein measurement
of mitochondrial preparations using the biuret assay. Pipetting errors
in sample loading were minimised through repetition of the western
transfer using the same mitochondrial preparation. Values shown, in
arbitrary units (a.u.), are means ± S.E. (n=3), two blots per
preparation on three separate, sibling paired mitochondrial prepara-
tions. ANT content was not significantly different between wild-type
and Ucp1KO mitochondria (paired Student’s t-test; p=0.16)
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both ANT and UCP1 (CAT and GDP, respectively).
However, mitochondria isolated from liver, skeletal muscle
or kidney did not have decreased basal proton conductance
in the absence of the abundant non-carrier protein, NNT.
Although not exhaustive, these results suggest that basal
proton conductance is a property shared by, and unique to,
mitochondrial inner membrane anion carrier proteins.
Previous studies using mitochondria isolated from
Ucp1KO or wild-type BAT suggested that UCP1 does not
contribute to basal proton conductance (Monemdjou et al.
1999), however, these studies were performed in the
absence of catalytic inhibition of ANT, so may have been
compromised by inducible proton conductance through
ANT, stimulated by an altered pool of endogenous fatty
acids. Shabalina et al. (2004) found that UCP1 knockout
did not affect non-phosphorylating oxygen consumption by
BAT mitochondria respiring on pyruvate, and concluded
that UCP1 has no role in basal proton conductance.
However, non-phosphorylating, GDP-inhibited respiration
with pyruvate as substrate is substantially lower than that
seen when BAT mitochondria are respiring with glycerol-3-
phosphate (Shabalina et al. 2004). The difference between
these substrates can be explained by different patterns of
control over respiration: with glycerol phosphate more
control over resting respiration may lie in proton conduc-
tance, making it easier to observe effects of changes in
proton conductance on respiration. If so, glycerol phosphate
is a more appropriate substrate than pyruvate for indirect
measurements of this type. Indeed, against the conclusion
to their paper, Shabalina et al. (2004) show (without
comment) that non-phosphorylating, state 4 respiration on
glycerol-3-phosphate was decreased in UCP1 knockouts.
Unfortunately this experiment was performed in the
absence of CAT and without looking at the proton leak
kinetics meaning it is not possible to discount the
contribution of inducible proton leak due to ANT, or
differences in mitochondrial membrane potential resulting
in differences in state 4 respiration observed. Earlier
experiments performed on BAT mitochondria isolated from
warm (low UCP1) or cold (high UCP1) adapted guinea pigs
(Locke et al. 1982; Rial and Nicholls 1984) or rats
(Goubern et al. 1990) showed no apparent difference in
basal proton conductance in the presence of GDP. In none
of these studies were differences in fatty acid stimulated
Fig. 3 Contribution of NNT to basal proton leak. a–c Proton leak
kinetics were measured in mitochondria from wild-type (open
squares) or NntKO mice (closed triangles) isolated from (a) liver,
(b) kidney or (c) skeletal muscle (SkM) after energization with 4 mM
succinate. Note all data are plotted on the same scale, with the
horizontal axes truncated at 100 mV, making the curves for liver
appear abnormally shallow. (d) Interpolation at 157 mV (the highest
potential common to all experiments—solid vertical lines in A, B and
C) allows direct comparison of proton leak rates (measured as oxygen
consumption in the presence of oligomycin) between the different
genotypes and tissues. Values are means ± S.E.M. of two (a), seven
(b) and three (c) experiments. N/S indicates no significant difference
between wild-type and NntKO samples (Student’s t-test)
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leak through ANT accounted for. It is possible that the
inducible proton conductance of ANT is higher in cold
adapted animals due, for instance, to higher contaminating
FFA in the mitochondrial preparation. Of interest, Goubern
et al. (1990) showed differences in basal proton conduc-
tance between warm and cold adapted rats fed on an
essential fatty acid deficient diet but these differences were
interpreted as due to changes in fatty acid composition—
they might actually have been due to differences in basal
leak through UCP1. In our paper, we have looked at basal
proton leak through UCP1 under more carefully controlled
conditions. We minimized the effect of endogenous fatty
acids on inducible proton conductance firstly by measuring
proton leak kinetics in the presence of high concentrations
of the fatty acid buffer BSA, and secondly through
inhibition of known inducible leak pathways. Inhibition of
ANT was particularly important because this FFA-
activatable uncoupling protein has been reported to be
upregulated in BAT mitochondria from UCP1 knockout
mice (Shabalina et al. 2006), although we did not replicate
this result (Fig. 2). Similar to the conclusion of Shabalina
et al. (2004), work by Beck et al. (2006, 2007) suggested
that there were no differences in current after a potential
was applied to a planar lipid bilayer containing or not
containing UCP1 protein. While this appears to be contrary
to our findings, it should be highlighted that the planar lipid
bilayer experiments were performed in artificial lipids that
may not behave in the same way as physiological mem-
branes. Additionally, the voltages applied to the planar lipid
bilayers for the relevant conductance estimations were very
low (<50 mV) compared to those measured in our experi-
ments (∼150 mV). The low membrane potentials used by
Beck et al. (2006, 2007) may mask the membrane potential-
dependent, non-ohmic basal proton conductance through
UCP1 observed in our experiments. Indeed, this interpreta-
tion is supported by our kinetic analysis of proton leak
(Fig. 1) where the curves, ± UCP1, become indistinguishable
towards lower potentials.
Other studies have shown that, for example, surface area
(Crichton et al. 2009) and phospholipid content (Ocloo
et al. 2007) do not differ significantly between the wild-
type and Ucp1KO models. This suggests that, while factors
other than UCP1 content may influence basal proton
conductance to some extent, they are unlikely to account
for the large changes observed. We therefore conclude that
a mitochondrial carrier other than ANT is able to promote
basal proton leak. Of mitochondrial carriers, only ANT, the
phosphate carrier and UCP1 (in BAT) constitute a sizeable
share of mitochondrial inner membrane protein content and
it is therefore difficult to assess basal proton conductance of
other mitochondrial carrier protein family members. The
lack of effect on basal proton conductance of ablation of
each of the mitochondrial carrier family proteins in yeast
(Roussel et al. 2002) may be due to their low individual
abundance rather than their inability to catalyze basal
proton conductance. In contrast, the absence of NNT (an
inner membrane protein from a different family that is also
present at significant concentrations) did not affect basal
proton conductance so this is not an intrinsic property of all
inner membrane proteins. NNT has been suggested to
catalyze proton leak as a result of a futile cycle in which
NNT uses protonmotive force to reduce NADP at the
expense of NADH, and NAD- and NADP-isocitrate
dehydrogenases re-equilibrate the two pools (Sazanov and
Jackson 1994). We find no evidence that such a proton
conductance pathway is significant under resting conditions
in isolated mitochondria, because ablation of NNT does not
alter basal proton conductance. In addition, significant
futile proton cycling involving NNT should decrease
weight gain in animals, but we found no differences in
body mass between wild-type and NntKO animals (not
shown). These data are inconsistent with NNT functioning
in a significant energy-dissipating cycle either in isolated
mitochondria or in vivo.
We conclude that basal proton conductance is catalyzed
not only by ANT, as previously reported (Brand et al.
2005), but also by UCP1 in BAT mitochondria, where it is
abundant. It is not catalyzed by NNT, an abundant
membrane protein from a different protein family. By
extension, we hypothesize that other members of the
mitochondrial anion carrier family also contribute to basal
proton conductance. Together, the basal proton conductance
of many anion carriers at low concentration may account
for the 34–50% of basal proton conductance not accounted
for by ANT in muscle mitochondria (Brand et al. 2005).
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